The global brain monitoring market size was valued at USD 7 billion in 2025 and is projected to grow from USD 7.43 billion in 2026 to USD 12.03 billion by 2034, registering a CAGR of 6.2% during the forecast period from 2026 to 2034. North America dominated the brain monitoring market with a market share of 38.5% in 2025.
Brain monitoring involves the continuous or periodic assessment of brain activity and function using technologies such as electroencephalography (EEG), intracranial pressure monitors, cerebral oximetry, and other neurophysiological tools. It is commonly used in intensive care, neurology, anesthesia, and neurosurgery to detect abnormalities, assess brain health, and support timely clinical decision-making.
Download a Free Sample To learn more about this report,
Shift Toward Wearable Dry-Electrode EEG Systems
Pressure to reduce the preparation time, discomfort, and limitations of conventional wet EEG electrodes is supporting the shift toward wearable dry-electrode systems; a 2025 Scientific Reports study involving 32 participants found that dry-electrode EEG was faster and easier to use while providing performance comparable to standard EEG for several applications.
Development of Flexible and Textile-Based EEG Wearables
Advances in flexible materials and textile-based electronics are further moving EEG devices toward conformable and lightweight formats for long-duration monitoring; a 2025 study developed an 8-channel stretchable e-textile EEG cap with flexible dry electrodes and knitted electrode wires, with the textile wires tolerating up to 3,200 cycles at 40% strain.
Growth in Neurosurgical Procedures and Expansion of Neurodiagnostic Centers and Specialized Clinics Drive Market
The growth in neurosurgical procedures is increasing demand for brain monitoring systems that help clinicians assess neurological function during complex interventions. Higher procedure volumes create greater requirements for EEG, intracranial monitoring, and intraoperative neurophysiological monitoring equipment. For example, intraoperative monitoring can help surgical teams track neural activity and identify potential neurological changes during brain or spine procedures. Greater use of these procedures increases procurement of monitoring equipment and related accessories by hospitals. This expanding surgical application base therefore supports demand in the brain monitoring market.
The expansion of neurodiagnostic centers and specialized clinics is increasing demand for brain monitoring equipment by creating more facilities dedicated to neurological assessment and disease management. A broader network of specialized centers increases testing capacity for conditions that require EEG and other neurological monitoring methods. For example, specialized epilepsy clinics use EEG monitoring to evaluate abnormal electrical brain activity and support clinical diagnosis. Higher testing capacity increases purchases of monitoring systems and related services, expanding the equipment supply requirements of healthcare providers. The growing neurodiagnostic infrastructure therefore supports market demand.
Shortage of Skilled Healthcare Professionals and Complexity of Operating Advanced Monitoring Systems Restrain Market Expansion
Limited availability of trained specialists can make it difficult to operate brain monitoring devices and accurately interpret complex neurological data. Additional training requirements can increase implementation time and operational costs for healthcare facilities. This constraint can reduce effective utilization and slow adoption of advanced brain monitoring technologies.
Advanced brain monitoring systems often require specialized setup, calibration, data handling, and interpretation procedures. Operational complexity can increase the workload for healthcare staff and create challenges in facilities with limited technical expertise. These factors can delay implementation and limit adoption across healthcare settings.
Integration of Brain Monitoring with Digital Health Platforms and Expansion of Brain Monitoring in Clinical Research Offer Growth Opportunities
Hospitals, telehealth providers, and digital health companies can connect brain-monitoring devices with patient-management platforms for centralized neurological data. Companies such as Natus Medical and Nihon Kohden can create revenue through connected monitoring solutions, software integration, and data-management services. Interoperable platforms can also support recurring software and service revenue.
Pharmaceutical companies, biotechnology firms, and CROs can use brain-monitoring systems to collect neurological data during clinical studies. Companies such as Compumedics and Natus Medical can generate revenue through research-grade equipment, study services, and data-analysis solutions. Long-term clinical research programs can support repeat equipment and service purchases.
Data Privacy and Cybersecurity Risks and High Volume of Complex Brain Data Hinders Growth
Connected brain-monitoring devices transmit sensitive neurological and patient information, increasing exposure to cybersecurity and data-privacy risks. A security incident affecting connected medical devices can disrupt clinical operations and reduce healthcare providers' willingness to deploy networked monitoring technologies at scale.
Advanced EEG, neuroimaging, and multimodal monitoring systems generate large volumes of continuous data that require efficient storage, processing, and interpretation. For example, continuous EEG monitoring in intensive care units can generate hours of recordings per patient, creating data-management and review burdens that can limit broader deployment.
By Application
The traumatic brain injury segment accounted for a share of 24% in 2025, owing to the need for continuous assessment of neurological status and brain function following traumatic injuries. The epilepsy segment supports monitoring of abnormal electrical activity, while the Parkinson's disease segment is associated with neurological assessment and disease management. The dementia segment supports evaluation of cognitive and neurological changes, while the stroke segment is used for monitoring brain function following cerebrovascular events.
The dementia segment is expected to grow at a CAGR of 7.4% during the forecast period 2026-2034, driven by increasing demand for neurological assessment and monitoring as cognitive disorders require ongoing evaluation. The traumatic brain injury, epilepsy, Parkinson's disease, and stroke segments continue to support demand through their respective neurological monitoring requirements.
Request Customizationto receive a tailored report.
By End User
The hospitals segment accounted for a share of 62% in 2025, owing to the availability of advanced neurological diagnostic infrastructure and the need for comprehensive brain monitoring across acute and complex cases. The neurology centers segment provides specialized neurological assessment and monitoring, while the diagnostic centers segment supports brain monitoring through dedicated diagnostic services.
The neurology centers segment is expected to grow at a CAGR of 7.2% during the forecast period 2026-2034, driven by increasing demand for specialized neurological evaluation and disease monitoring. The hospitals and diagnostic centers segments continue to support brain monitoring through acute care and diagnostic testing.
By Product
The electroencephalography devices segment accounted for a share of 18.5% in 2025, owing to their established role in monitoring electrical brain activity and supporting neurological diagnosis. The magnetic resonance imaging devices segment provides structural brain imaging, while the computerized tomography devices segment supports rapid brain assessment. The cerebral oximeters segment enables monitoring of cerebral oxygenation, the intracranial pressure monitors segment supports assessment of pressure within the skull, and the transcranial Doppler devices segment evaluates cerebral blood flow. The sleep monitoring devices segment supports assessment of sleep-related neurological activity, while the electromyography devices segment evaluates neuromuscular activity. The magnetoencephalography devices segment provides non-invasive measurement of magnetic brain activity, the positron emission tomography devices segment supports functional and metabolic brain imaging, and the accessories segment includes supporting components used with brain monitoring systems.
The sleep monitoring devices segment is expected to grow at a CAGR of 7.5% during the forecast period 2026-2034, driven by increasing demand for monitoring sleep-related neurological activity and associated disorders. The electroencephalography, magnetic resonance imaging, computerized tomography, cerebral oximeters, intracranial pressure monitors, transcranial Doppler, electromyography, magnetoencephalography, positron emission tomography, and accessories segments continue to support diverse diagnostic and monitoring requirements.
By Medical Condition
The traumatic brain injury (TBI) segment accounted for a share of 19% in 2025, owing to the need for brain function and neurological status monitoring following traumatic injuries. The stroke segment supports monitoring of neurological changes following cerebrovascular events, while the epilepsy segment is associated with assessment of abnormal brain activity. The Parkinson's disease segment supports neurological monitoring, while the dementia segment is used for evaluating cognitive and neurological changes. The sleep disorders segment addresses monitoring requirements associated with disrupted sleep patterns, and the headache disorders segment supports neurological assessment. The Huntington's disease segment serves specialized monitoring requirements, while the other medical conditions segment includes additional neurological disorders.
The dementia segment is expected to grow at a CAGR of 7.5% during the forecast period 2026-2034, driven by increasing demand for ongoing assessment of cognitive and neurological changes. The traumatic brain injury, stroke, epilepsy, Parkinson's disease, sleep disorders, headache disorders, Huntington's disease, and other medical conditions segments continue to support brain monitoring across their respective clinical requirements.
Speak to an Analystto discuss market opportunities.
The North America brain monitoring market accounted for the largest regional share of 38.5% in 2025, supported by the substantial burden of neurological disorders, with a 2023 Global Burden of Disease analysis estimating 470 million people across the Americas were living with at least one nervous-system disorder, while neurological conditions are expected to remain a major healthcare burden requiring improved diagnosis and monitoring technologies.
The United States brain monitoring market is expected to benefit from the rising burden of neurological disorders, with the NIH reporting that the number of new dementia cases in the U.S. is projected to double by 2060, while the CDC projects nearly 14 million Americans to be living with Alzheimer’s disease by 2060, supporting demand for brain monitoring, diagnostic, and neurological assessment technologies. The Canada brain monitoring market is expected to benefit from the rising prevalence of neurological conditions, with Government of Canada projections indicating that Alzheimer’s disease and other dementia cases could increase from 461,700 in 2021 to 674,000 by 2031, while Parkinson’s disease/parkinsonism cases are projected to rise from 119,900 to 190,700 over the same period, supporting demand for neurological monitoring and diagnostic technologies.
Unlock Regional Insightsto access country-level data, & regional trends.
The Europe brain monitoring market is expected to grow at a CAGR of 7.6% during the forecast period 2026–2034, showcasing the fastest-growing regional market, supported by the rising neurological disease burden, with the European Commission reporting that around 165 million Europeans currently live with a brain disorder and estimating that one in three people will experience a neurological or mental disorder during their lifetime, while the region’s aging population is expected to further increase demand for brain-health monitoring and diagnostic technologies.
The UK brain monitoring market is expected to benefit from the rising neurological disease burden, with the UK government projecting the number of people living with dementia to increase from around 944,000 currently to more than 1.1 million by 2030, 1.4 million by 2040, and 1.6 million by 2050, supporting demand for brain monitoring and neurological assessment technologies. The Germany brain monitoring market is expected to benefit from the rising burden of dementia, with Germany’s Federal Ministry of Health estimating that the number of people living with dementia could increase from around 1.8 million currently to approximately 2.8 million by 2050, while current projections indicate 2.6–2.8 million people aged 65 and above could have dementia by 2055, supporting demand for neurological monitoring and diagnostic technologies. The France brain monitoring market is expected to benefit from the growing neurological disease burden, with France’s Ministry of Health reporting that nearly 1.5 million people are currently affected by non-rare neurodegenerative diseases and projecting this number to double by 2050, supporting greater demand for brain monitoring, neurological assessment, and diagnostic technologies.
The Asia Pacific brain monitoring market accounted for a regional share of 22.5% in 2025, supported by the region’s aging population and rising neurological-care needs, with WHO projecting the population aged 60 and above in South-East Asia to increase from 12.2% in 2024 to 22.9% by 2050, while the number of people aged 65 and above in the Western Pacific Region is expected to double by 2050, increasing demand for neurological assessment and brain monitoring technologies.
The Japan brain monitoring market is expected to benefit from the rising burden of cognitive disorders, with Japan’s government projecting the number of people aged 65 and above with dementia to increase from 4.43 million in 2022 to 5.84 million by 2040, while those with mild cognitive impairment (MCI) are expected to reach 6.13 million, increasing demand for cognitive assessment, neurological monitoring, and brain-health technologies. The China brain monitoring market is expected to benefit from continued population aging, with WHO projecting the number of people aged 60 and above in China to increase substantially through 2050, while the global population aged 60 and above is projected to reach 2.1 billion by 2050, supporting greater demand for neurological assessment, cognitive monitoring, and brain-health technologies.
The South Korea brain monitoring market is expected to benefit from rapid population aging, with the National Assembly Budget Office projecting that people aged 65 and above will exceed 40% of the population by 2050, increasing the long-term need for neurological assessment, cognitive monitoring, and brain-health technologies. The India brain monitoring market is expected to benefit from the rising burden of dementia, with NITI Aayog projecting the number of people living with dementia in India to increase from an estimated 4 million to 13.4 million by 2050, while nearly 45% of India’s disease burden is projected to be borne by older adults by 2030, supporting demand for brain monitoring and neurological assessment technologies.
The brain monitoring market is moderately fragmented, with participation from medical device manufacturers, neurotechnology companies, diagnostic equipment providers, healthcare technology firms, and specialized brain-monitoring solution developers. The leading players in the global brain monitoring market include Medtronic Plc., Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, and Siemens Healthineers, which together represent a significant share of the market, although a reliable publicly disclosed cumulative percentage for these exact five companies is not available in the cited sources.
Established players compete primarily on monitoring accuracy, signal quality, device reliability, regulatory approvals, product portfolios, clinical validation, integration with hospital systems, and established healthcare-provider relationships. Emerging and regional players compete through compact and portable devices, wireless monitoring, AI-enabled signal analysis, cloud connectivity, application-specific solutions, lower-cost systems, and user-friendly technologies for decentralized or home-based monitoring. Competition is also shaped by technological innovation, interoperability, data security, ease of use, and the ability to translate complex neurological data into clinically useful insights.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Germany Surgical Equipment Market Size, Share and Forecast to 2034
Europe Surgical Equipment Market Size, Top Share and Forecast to 2034
Biofeedback Instrument Market Size, Share, Growth, Analysis, 2034
Cardiac Assist Devices Market Size, Share, Growth, 2034
Radiosurgery Market Size, Share, Growth, Analysis, Report, 2034
Interventional Cardiology Devices Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com